By a News Reporter-Staff News Editor at Marketing Weekly News -- Merck, known as MSD outside the United States and Canada (NYSE: MRK), and Endocyte Inc. (NASDAQ: ECYT), announced that the European Medicines Agency (EMA) has accepted for review the marketing authorization application (MAA) filings ... (Publication: Marketing Weekly News)
↧